Edwards Lifesciences EPS Diluted Growth Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 121.72  1.23  1.02%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed EPS Diluted Growth of Edwards Lifesciences Corporation with missing and latest data points interpolated. Measures the growth in Earnings per Diluted Share over the specified period.
EPS Diluted Growth  10 Years Trend  
Decreasing
Slightly volatile
 EPS Diluted Growth 
      Timeline 

Edwards Lifesciences EPS Diluted Growth Over Time

2016-12-31 (0.4) 
2017-12-31 (0.4) 
2018-12-31 (0.47) 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  0.11
Geometric Mean  0.28
Coefficient Of Variation  463.04
Mean Deviation  0.38
Median  0.076087
Standard Deviation  0.49
Sample Variance  0.24
Range  1.64
R Value (0.42)
Mean Square Error  0.22
R Squared  0.17
Significance  0.16
Slope (0.052657)
Total Sum of Squares  2.93

Currently Trending

VHT   
 PCX 
Purchased over 90 shares of
few hours ago ago
Traded for 162.09
VWO   
 PCX 
Purchased over 90 shares of
few hours ago ago
Traded for 48.23
MYSZ   
 NASDAQ 
Purchased over 100 shares of
few hours ago ago
Traded for 2.66